Aureus Asset Management LLC Has $5.96 Million Stake in Morgan Stanley (NYSE:MS)

Aureus Asset Management LLC raised its position in Morgan Stanley (NYSE:MSFree Report) by 1.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 57,159 shares of the financial services provider’s stock after purchasing an additional 617 shares during the quarter. Aureus Asset Management LLC’s holdings in Morgan Stanley were worth $5,958,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of MS. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of Morgan Stanley by 382.4% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,597,800 shares of the financial services provider’s stock valued at $166,555,000 after purchasing an additional 1,266,600 shares during the period. Fisher Asset Management LLC raised its stake in shares of Morgan Stanley by 2.7% in the 3rd quarter. Fisher Asset Management LLC now owns 22,404,981 shares of the financial services provider’s stock valued at $2,335,495,000 after purchasing an additional 590,872 shares during the period. Zurich Insurance Group Ltd FI acquired a new stake in shares of Morgan Stanley in the 2nd quarter valued at about $43,850,000. Erste Asset Management GmbH acquired a new stake in shares of Morgan Stanley in the 3rd quarter valued at about $46,067,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Morgan Stanley by 4.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,454,177 shares of the financial services provider’s stock valued at $881,263,000 after purchasing an additional 385,780 shares during the period. Institutional investors and hedge funds own 84.19% of the company’s stock.

Morgan Stanley Trading Up 0.3 %

Morgan Stanley stock opened at $131.61 on Monday. Morgan Stanley has a 52 week low of $78.21 and a 52 week high of $136.24. The stock has a market capitalization of $212.03 billion, a P/E ratio of 20.03, a PEG ratio of 1.22 and a beta of 1.34. The stock has a 50-day simple moving average of $119.29 and a 200 day simple moving average of $106.46. The company has a debt-to-equity ratio of 3.14, a quick ratio of 0.80 and a current ratio of 0.80.

Morgan Stanley (NYSE:MSGet Free Report) last issued its quarterly earnings data on Wednesday, October 16th. The financial services provider reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.31. Morgan Stanley had a return on equity of 12.58% and a net margin of 10.64%. The company had revenue of $15.38 billion during the quarter, compared to analysts’ expectations of $14.27 billion. Analysts expect that Morgan Stanley will post 7.32 earnings per share for the current year.

Morgan Stanley Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Thursday, October 31st were issued a dividend of $0.925 per share. This represents a $3.70 dividend on an annualized basis and a dividend yield of 2.81%. The ex-dividend date was Thursday, October 31st. Morgan Stanley’s dividend payout ratio is presently 56.32%.

Insider Transactions at Morgan Stanley

In other news, Director Stephen J. Luczo sold 60,000 shares of the business’s stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $119.17, for a total transaction of $7,150,200.00. Following the completion of the sale, the director now owns 138,363 shares in the company, valued at $16,488,718.71. The trade was a 30.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.24% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Hsbc Global Res downgraded Morgan Stanley from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 26th. Royal Bank of Canada raised their price objective on Morgan Stanley from $108.00 to $122.00 and gave the company a “sector perform” rating in a report on Thursday, October 17th. UBS Group raised their price objective on Morgan Stanley from $102.00 to $112.00 and gave the company a “neutral” rating in a report on Tuesday, October 8th. Citigroup raised their price objective on Morgan Stanley from $105.00 to $135.00 and gave the company a “neutral” rating in a report on Monday, November 25th. Finally, HSBC cut Morgan Stanley from a “buy” rating to a “hold” rating and raised their price objective for the company from $128.00 to $131.00 in a report on Tuesday, November 26th. Eleven analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $118.00.

Check Out Our Latest Research Report on Morgan Stanley

About Morgan Stanley

(Free Report)

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.

Further Reading

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.